Sangamo Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on Sangamo Therapeutics Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Sangamo Therapeutics Inc Strategy Report

  • Understand Sangamo Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Sangamo Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Sangamo Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sangamo Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

H. Stewart Parker

Chairman Executive Board Since: 2017 Age: 67

Ms. H. Stewart Parker has been the Chairman of the company since June 2017. Ms. Parker joined Sangamo as a Director in June 2014. From 2011 to 2013, she served as the Chief Executive Officer of the Infectious Disease Research Institute (IDRI). Prior to this, Ms. Parker founded Targeted Genetics Corporation in 1992 and served various roles in the company including the President, Chief Executive Officer and Director until 2008. From 1991 to 1993, she served at Receptech Corporation as the President and Director. Previously, Ms. Parker served as the Director at BIO a biotechnology company. Currently, she serves as member of board of Directors of different companies including IDRI, Oncogenex technologies and C3 Jian Inc.

Read Hide full bio of H. Stewart Parker

Sandy Macrae, Ph.D.

Chief Executive Officer; Director; President Executive Board Since: 2016 Age: 60

Dr. Sandy Macrae has been the President, Chief Executive Officer and Director of the company since June 2016. He also serves on the board of directors of 4D Pharma plc. Prior to this role, Mr. Macrae served as the Global Medical Officer of Takeda Pharmaceuticals, from 2012 to March 2016. From 2009 to 2012, he served at GlaxoSmithKline (GSK) as the Senior Vice President, Emerging Markets Research and Development (R&D). From 2007 to 2008, Mr. Macrae also served as the Vice President, Business Development at GSK. Previously, he worked for SmithKline Beecham.

Read Hide full bio of Sandy Macrae, Ph.D.

Prathyusha Duraibabu

Chief Financial Officer Senior Management Since: 2021 Age: 44

Ms. Prathyusha Duraibabu has been the Chief Financial Officer of the company since 2021. Prior to this, she served as the Corporate Controller at Pacific Biosciences of California, Inc.

Read Hide full bio of Prathyusha Duraibabu

Mark McClung

Executive Vice President; Chief Operating Officer Senior Management Since: 2021 Age: 60

Mr. Mark McClung has been the Executive Vice President and Chief Operating Officer of the company since 2021. Previously, he served as the Chief Business Officer of the company since 2020. Prior to this, he served as General Manager of Global Oncology Commercial at Amgen. Previously, Mr. McClung served at GlaxoSmithKline as Head of Global Commercial for GSK Oncology.

Read Hide full bio of Mark McClung

Whitney Jones

Senior Vice President; Chief People Officer Senior Management Since: 2020

Mr. Whitney Jones has been the Chief People Officer and Senior Vice President of Sangamo Therapeutics Inc since 2020. Prior to this, he served as the Chief People Officer at LendingClub. Before that he served as the Global Head of Human Resources at Grifols.

Read Hide full bio of Whitney Jones
Gain a 360-degree view of Sangamo Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Sangamo Therapeutics Inc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer